Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

The Lancet Oncology

Volumn 13, Issue 7, 2012, Pages 679-687

  Rödel, Claus ^a   Liersch, Torsten ^b   Becker, Heinz ^b   Fietkau, Rainer ^c   Hohenberger, Werner ^c   Hothorn, Torsten ^d,e   Graeven, Ullrich ^f   Arnold, Dirk ^g   Lang Welzenbach, Marga ^c   Raab, Hans Rudolf ^h   Sülberg, Heiko ⁱ   Wittekind, Christian ^j   Potapov, Sergej ^c   Staib, Ludger ^k   Hess, Clemens ^b   Weigang Köhler, Karin ^l   Grabenbauer, Gerhard G ^m   Hoffmanns, Hans ^f   Lindemann, Fritz ⁿ   Schlenska Lange, Anke ^o   Folprecht, Gunnar ^p   Sauer, Rolf ^c   more..

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f KLINIKEN MARIA HILF GMBH   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h KLINIKUM OLDENBURG   (Germany)

ⁱ WiSP Research Institute   (Germany)

^j UNIVERSITY OF LEIPZIG   (Germany)

^k KLINIKUM ESSLINGEN   (Germany)

^l KLINIKUM NÜRNBERG   (Germany)

^m KLINIKUM COBURG   (Germany)

ⁿ Klinikum Friedberg   (Germany)

^o KRANKENHAUS BARMHERZIGE BRÜDER   (Germany)

^p UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; FATIGUE; FEMALE; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MONOTHERAPY; MOTOR NEUROPATHY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROCTITIS; RADIATION DERMATITIS; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA; RECTUM SURGERY; SENSORY NEUROPATHY; STOMATITIS; THROMBOCYTOPENIA; TOTAL MESORECTAL EXCISION SURGERY; TREATMENT RESPONSE; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS;

EID: 84863106037     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70187-0     Document Type: Article

References (22)

1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740.
2. Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006, 24:4620-4625.
3. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123.
4. Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009, 27:5124-5130.
5. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009, 373:811-820.
6. van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011, 12:575-582. for the Dutch Colorectal Cancer Group.
7. Rödel C, Grabenbauer GG, Papadopoulos T, et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003, 21:3098-3104.
8. Rödel C, Liersch T, Hermann RM, et al. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 2007, 25:110-117.
9. Schmiegel W, Reinacher-Schick A, Arnold D, et al. Update S3-guideline colorectal cancer 2008. Z Gastroenterol 2008, 46:799-840. (in German).
10. International Union Against Cancer TNM classification of malignant tumours 2002, John Wiley & Sons, Hoboken, NJ. 6th edn. L.H. Sobin, C. Wittekind (Eds.).
11. Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009, 373:821-828.
12. Dworak O, Keilholz L, Hoffmann A Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997, 12:19-23.
13. R: a language and environment for statistical computing 2012, R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria, (accessed Feb 29, 2012). http://www.R-project.org/.
14. Aschele C, Cionini L, Lonardi S, et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 2011, 29:2773-2780.
15. Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010, 28:1638-1644.
16. Roh MS, Yothers GA, O'Connell MJ, et al. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. Proc Am Soc Clin Oncol 2011, 29(suppl). abstract 3503.
17. Rich TA, Shepard RC, Mosley ST Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. J Clin Oncol 2004, 22:2214-2232.
18. Hofheinz RD, Wenz F, Post S, et al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol 2012, published online April 13. 10.1016/S1470-2045(12)70116-X.
19. Valentini V, Beets-Tan R, Borras JM, et al. Evidence and research in rectal cancer. Radiother Oncol 2008, 87:449-474.
20. Nagtegaal ID, van de Velde CJ, van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002, 20:1729-1734.
21. Fernandez-Martos C, Pericay C, Aparicio J, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol 2010, 28:859-865.
22. Chua YJ, Barbachano Y, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 2010, 11:241-248.